Methylmalonic Acidemia (MUT-Related) (MUT)

Methylmalonic acidemia (MUT-related) is a pan-ethnic, autosomal recessive disease caused by pathogenic variants in the MUT gene. The most common presentation is during the newborn period, where a previously normal infant begins vomiting, and develops lethargy and hypotonia due to an excess of ammonia in the blood. Without immediate treatment, the resulting brain disease can be fatal. Patients can also present later in infancy or childhood after a period of normal development. Although the onset may be later, this form of the disease may also be fatal if not identified and treated promptly. Even with treatment, patients may develop intellectual disability, impaired function of the kidneys, vision loss, growth failure and pancreatitis. Life expectancy is variable depending on the number and length of metabolic crises and the severity of the resulting damage, but there is significant mortality associated with all ages. Several specific variants may be associated with the development of either the early or later-onset form, but some variants may not have a known genotype-phenotype correlation.

Disease Name
 GeneGuaranteed Exons 
 Inheritance Ethnicity
 Carrier Frequency
 Detection Rate
Residual Risk

Methylmalonic Acidemia (MUT-Related) MUT2-6, 8-13 [13] (*25)ARCaucasian1 in 22422%0.00348432055749129
Methylmalonic Acidemia (MUT-Related) MUT2-6, 8-13 [13] (*25)ARAfrican1 in 17752%0.00271739130434783
Methylmalonic Acidemia (MUT-Related) MUT2-6, 8-13 [13] (*25)ARHispanic1 in 38365%0.000915750915750916
Methylmalonic Acidemia (MUT-Related) MUT2-6, 8-13 [13] (*25)ARAsian1 in 5350%0.00952380952380952
Methylmalonic Acidemia (MUT-Related) MUT2-6, 8-13 [13] (*25)ARWorldwide1 in 38346%0.00141242937853107